维普期刊资源整合服务平台（V6.5）

61篇 您的检索式：作者名="BOOGAERTS M"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Clinical experience with itraconazole in ssystemic fungal infections显示文摘	Boogaerts M Maertens J	2001	Drugs2001，61，1：	1
2	Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad spectrum antibacterial therapy: a randomized, controlled trial显示文摘	Boogaerts M Winston DJ Bow EJ	2001	Ann Intern Med2001，735，6：	1
3	Itraconazole(IT)compared with amphotericin B (AMB)as empirical therapy for persistent fever of unknown origin(FUO)in neutropenic patients(PTS)显示文摘	Boogaerts M Garber G Winston D	1999	Bone Marrow Transplant1999，23，1：	1
4	Assessing risk factors for systemic fungal infections显示文摘	Maertens J Vrebos M Boogaerts M	2001	Eur J Cancer Care (Engl)2001，10，：	1
5	Retoconazole vs itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies显示文摘	Tricot G Joosten E Boogaerts M A	1987	Rev Infect Dis1987，9，1：	1
6	Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy显示文摘	Boogaerts M Winston DJ Bow EJ	2001	Ann Intern Med2001，135，：	1
7	Assessing risk factors for systemic fungal infactions显示文摘	Maertens J Vrebos M Boogaerts M	2001	Eur J Cancer Caer (Engl)2001，10，1：	1
8	Assessing risk factors for systemic fungal infections 显示文摘	Maertens J Vrebos M Boogaerts M	2001	Eur J Cancer Care ( Engl )2001，10，1：	1
9	Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy:a randomized,controlled trial显示文摘	Boogaerts M Winston DJ Bow EJ	2001	Ann Intern Med2001，135，：	1
10	Assessing risk factors for systemic fungal infections显示文摘	Maertens J Vrebos M Boogaerts M	2001	Eur J Cancer Care2001，10，1：	1
11	Cytogenetics of hybrid a- cute leukemia 显示文摘	Cuneo A Boogaerts M Ferrant A	1995	Leukemia and Lymphoma1995，11，：	1
12	Assessing risk factors for systemic fungal infections 显示文摘	Maertens J Vrebos M Boogaerts M	2001	Eur J Cancer Care (Engl)2001，10，1：	1
13	An inv(16)(p13q22) positive acute myeloid leukaemia relapsing as acute precursor B-cell lymphoblastic leukaemia显示文摘	van der Velden VH Boogaerts M	2004	Haematologica2004，89，8：	1
14	Clinical experience with itraeonazole in systemic fungal infections显示文摘	Boogaerts M Maertens J	2001	Drug2001，61，1：	1
15	Beyond araemia management:Evolving role of erythropoietin therapy in neurological disorders,multiple myeloma and tumour hypoxia models 显示文摘	Boogaerts M Mittelman M Vaupel P	2005	Oncology2005，69，12：	1
16	Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg(gemtuzumab ozogamicin)显示文摘	Boogaerts M Estey E	2002	Leukemia2002，16，9：	1
17	Assessing risk factors for systemic fungal infections 显示文摘	Maertens J Vrebos M Boogaerts M	2001	Eur J Cancer Care2001，10，1：	1
18	Telaprevir for retreatment of HCV infection 显示文摘	Zeuzem S Andreone P Pol S Lawitz E Diago M Roberts S Foeaccia R Younossi Z Foster GR Horban A Ferenci P Nevens F Mullhaupt B Pockros P Terg R Shouval D van Hoek B Weiland O Van Heeswijk R De Meyer S Luo D Boogaerts G Polo R Picchio G Beumont M REALIZE Study Team	2011	N Engl J Med2011，364，25：	1
19	Liposomal nystatin in patients with invasiveaspergillosis refractory to or intolerant of amphotericin B 显示文摘	Offner F Krcmery V Boogaerts M	2004	Antimicrob Agents Chemother2004，48，12：	1
20	The role of aggres- sive chemotherapy in the treatment of the myelodys- plastic syndromes显示文摘	TRICOT G BOOGAERTS M A	1986	Br J Haematol1986，63，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示